Faithward Advisors LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 3,111 shares of the financial services provider’s stock, valued at approximately $577,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Solstein Capital LLC purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $25,000. KERR FINANCIAL PLANNING Corp purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $27,000. Golden State Wealth Management LLC purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $27,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $28,000. Finally, City Holding Co. purchased a new position in Marsh & McLennan Companies during the 4th quarter valued at about $29,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Trading Up 0.3%
Shares of MRSH stock opened at $166.67 on Wednesday. Marsh & McLennan Companies, Inc. has a 52 week low of $156.60 and a 52 week high of $220.32. The company has a market capitalization of $80.52 billion, a PE ratio of 20.83, a P/E/G ratio of 2.42 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.
Wall Street Analysts Forecast Growth
MRSH has been the subject of a number of recent research reports. Wells Fargo & Company lowered their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research report on Thursday, April 9th. Morgan Stanley lowered their price target on shares of Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research report on Monday, April 6th. Piper Sandler lowered their price target on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. Barclays lowered their price target on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Finally, Weiss Ratings cut shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. One equities research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $200.19.
Read Our Latest Analysis on MRSH
Insider Activity at Marsh & McLennan Companies
In other news, CEO John Q. Doyle sold 16,656 shares of Marsh & McLennan Companies stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. The trade was a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by corporate insiders.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
